How Fas ligand affects eye health and glaucoma
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
This study is looking at a protein called Fas ligand to see how it affects eye health and glaucoma, with the hope of finding new ways to help protect vision by understanding how this protein influences the survival of important eye cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Schepens Eye Research Institute NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11018530 on NIH RePORTER |
What this research studies
This research investigates the role of Fas ligand, a protein involved in cell death, in maintaining eye health and its connection to glaucoma. The study focuses on how the cleavage of Fas ligand influences the survival of retinal ganglion cells, which are crucial for vision. By examining the balance between membrane-bound and soluble forms of Fas ligand, the research aims to understand how this balance affects inflammation and cell death in the eye. Patients may benefit from insights that could lead to new treatments for glaucoma and other eye diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for glaucoma or those already diagnosed with the condition.
Not a fit: Patients with eye conditions unrelated to glaucoma or those who do not have any retinal health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating glaucoma, potentially preserving vision for many patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of Fas ligand in eye health, suggesting that this approach may lead to significant advancements in glaucoma treatment.
Where this research is happening
Boston, United States
- Schepens Eye Research Institute — Boston, United States (Active)
Researchers
- Principal investigator: Gregory-Ksander, Meredith — Schepens Eye Research Institute
- Study coordinator: Gregory-Ksander, Meredith
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.